SCHEMBL22445906

SCHEMBL22445906

CCOC(=O)c1c(C)cc(C=NNS(=O)(=O)c2ccc(C)cc2)nc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.46
▸ MAPT P10636 8/20 0.46
▸ LMNA P02545 4/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KMT2A Q03164 9/20 0.46
▸ GAA P10253 1/20 0.46
▸ MEN1 O00255 7/20 0.44
▸ NPSR1 Q6W5P4 4/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ RBM39 Q14498 1/20 0.43
▸ RRM1 P23921 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22445905 1.00 ALDH1A1 (0.46) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL22453888 0.80 KDM4E (0.37) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL22454046 0.79 ALDH1A1 (0.48) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL22454037 0.76 SMN1; SMN2 (0.44) ALDH1A1MAPTLMNASMN1; SMN2GAA
SCHEMBL29664878 0.73 ALDH1A1 (0.51) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL31604889 0.72 POLB (0.55) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL22445798 0.71 CYP3A4 (0.52) ALDH1A1MAPTLMNASMN1; SMN2GAA
SCHEMBL3177473 0.71 LMNA (0.58) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL30835598 0.71 ALDH1A1 (0.53) ALDH1A1MAPTLMNASMN1; SMN2KMT2A
SCHEMBL30835597 0.71 ALDH1A1 (0.53) ALDH1A1MAPTLMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162192-A1 INDAZOLES AS LRRK2 INHIBITORS ESCAPE Bio, Inc. 2022-05-26 — — US disclosed
WO-2020191261-A1 INDAZOLES AS LRRK2 INHIBITORS E-SCAPE BIO, INC. (US) 2020-09-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162192-A1 INDAZOLES AS LRRK2 INHIBITORS LRRK2, PARK7, PINK1 ALDH1A1 2607/4885MAPT 9/4885LMNA 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback